(Q97046475)

English

Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

MATCH Treatment Subprotocol S2: Phase II Study of Trametinib in Patients With Tumors With GNAQ or GNA11 Mutations (English)
0 references
0 references
0 references
25 February 2016
0 references
16 May 2019
0 references
4
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit